PEPTIDEREPORT

Primary regulatory

Bacteriostatic Water for Injection: FDA Drug Label (Hospira/Pfizer)

FDA-approved drug label for Bacteriostatic Water for Injection (Hospira), containing 0.9% benzyl alcohol as a preservative, labeled for multi-dose use and not for neonatal use due to benzyl alcohol toxicity risk.

U.S. Food and Drug AdministrationPublished 2010-01-01Accessed 2026-07-08

Open original source

Registry record

Source metadata

Publisher
U.S. Food and Drug Administration
Source type
Primary regulatory
Registry ID
fda-bacteriostatic-water-label

Source usage

Linked from 3 pages

Guide

Bacteriostatic Water Guide: What It Is, How It Differs From Sterile Water, and Why It Matters for Peptide Reconstitution

Guide

Peptide Terminology Glossary

Guide

Sterile vs Bacteriostatic Water: What Changes After the Seal Is Broken

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.